Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 11/20 | 0.43 |
| ▸ | ACACA | Q13085 | 11/20 | 0.43 |
| ▸ | PDE7A | Q13946 | 5/20 | 0.43 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15489227 | 0.93 | ACACB (0.46) | ACACBACACAPDE7ACES1KMT2A | |
| SCHEMBL13940440 | 0.88 | ACACB (0.43) | ACACBACACAPDE7ACES1KMT2A | |
| SCHEMBL15472956 | 0.87 | ACACB (0.44) | ACACBACACAPDE7ACES1 | |
| SCHEMBL12658145 | 0.85 | ACACB (0.47) | ACACBACACAPDE7AKMT2A | |
| SCHEMBL13879597 | 0.85 | ACACB (0.40) | ACACBACACAPDE7A | |
| SCHEMBL12329324 | 0.85 | ACACB (0.40) | ACACBACACAPDE7ACES1KMT2A | |
| SCHEMBL12362051 | 0.85 | ACACB (0.41) | ACACBACACAPDE7ACES1 | |
| SCHEMBL12231719 | 0.84 | ACACB (0.40) | ACACBACACAPDE7ACES1 | |
| SCHEMBL12329323 | 0.83 | ACACB (0.47) | ACACBACACAPDE7A | |
| SCHEMBL811962 | 0.83 | ACACB (0.55) | ACACBACACAPDE7AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9204640-B2 | 2-acyloxy-pyrrolin-4-ones | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-12-08 | — | — | US | disclosed |
| US-9204640-B2 | 2-acyloxy-pyrrolin-4-ones | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-12-08 | — | — | US | disclosed |
| EP-2681191-B1 | 2-ACYLOXY-PYRROLIN-4-ONES | BAYER IP GMBH (DE) | 2015-09-02 | — | — | EP | disclosed |
| US-20140057790-A1 | 2-ACYLOXY-PYRROLIN-4-ONES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2014-02-27 | — | — | US | disclosed |
| US-20140057790-A1 | 2-ACYLOXY-PYRROLIN-4-ONES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2014-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140057790-A1 | 2-ACYLOXY-PYRROLIN-4-ONES | ATL3, PLCG2, PLCG1 | ACACB 23/4885ACACA 59/4885PDE7A 2171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.